Evidence map›Paper›PMID 23046564›Full record

Trial reportNutrition journal2012

Comparison between the AA/EPA ratio in depressed and non depressed elderly females: omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters.

Angela Maria Rizzo, Paola Antonia Corsetto, Gigliola Montorfano, Annalisa Opizzi, Milena Faliva, Attilio Giacosa, Giovanni Ricevuti, Claudio Pelucchi, Bruno Berra, Mariangela Rondanelli

Open access · goldAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Nutrition journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 11 pooled it
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 11 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Omega-3 fatty acids for depression in adults.The Cochrane database of systematic reviews · 2021
    Pooled it
  3. Pooled it
  4. Effects of Omega 3 Fatty Acids on Main Dimensions of Psychopathology.International journal of molecular sciences · 2020
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Omega-3 fatty acids for depression in adults.The Cochrane database of systematic reviews · 2015
    Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Dietary Supplementations and Depression.Journal of multidisciplinary healthcare · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Angela Maria RizzoDipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via D, Trentacoste 2, Milan 20134, Italy. angelamaria.rizzo@unimi.it
Paola Antonia Corsetto
Gigliola Montorfano
Annalisa Opizzi
Milena Faliva
Attilio Giacosa
Giovanni Ricevuti
Claudio Pelucchi
Bruno Berra
Mariangela Rondanelli
Azienda di Servizi alla Persona di Pavia (Italy) · ITUniversity of Milan · ITFondazione Lanza · ITMario Negri Institute for Pharmacological Research · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDepression is one of the most frequently missed diagnoses in elderly people, with obvious negative effects on quality of life. Various studies have shown that long chain omega-3 polyunsaturated fatty acids (n-3 PUFA) may be useful in its management. Our objective was to evaluate whether a supplement containing n-3 PUFA improves depressive symptoms in depressed elderly patients, and whether the blood fatty acid pattern is correlated with these changes.

methodsThe severity of depressive symptoms according to the Geriatric Depression Scale (GDS), blood fatty acid composition and erythrocyte phospholipids were analyzed in 46 depressed females aged 66-95y, diagnosed with depression according to DSMIV, within the context of a randomized, double-blind, placebo-controlled trial. 22 depressed females were included in the intervention group (2.5 g/day of n-3 PUFA for 8 weeks), and 24 in the placebo group. We also measured immunological parameters (CD2, CD3, CD4, CD8, CD16, CD19 and cytokines (IL-5, IL-15).

resultsThe mean GDS score and AA/EPA ratio, in whole blood and RBC membrane phospholipids, were significantly lower after 2 months supplementation with n-3 PUFA. A significant correlation between the amelioration of GDS and the AA/EPA ratio with some immunological parameters, such as CD2, CD19, CD4, CD16 and the ratio CD4/CD8, was also found. Nevertheless, omega-3 supplementation did not significantly improve the studied immunological functions.

conclusionsn-3 PUFA supplementation ameliorates symptoms in elderly depression. The n-3 PUFA status may be monitored by means of the determination of whole blood AA/EPA ratio.

Indexed as

AgingDietary SupplementsAgedAged, 80 and overAntidepressive AgentsAntigens, CDArachidonic AcidCytokinesDepressionDiagnostic and Statistical Manual of Mental DisordersDouble-Blind MethodEicosapentaenoic AcidErythrocyte MembraneFatty Acids, Omega-3FemaleGeriatric AssessmentAntidepressive AgentsAntigens, CDArachidonic AcidCytokinesEicosapentaenoic AcidFatty Acids, Omega-3Phospholipids

Identifiers

PMID23046564
PMCPMC3499393
OpenAlexW2116452655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.